Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: A review

Drug and Alcohol Dependence

Volumn 75, Issue 1, 2004, Pages 3-9

  McDonough, Michael ^a,c   Kennedy, Noel ^b   Glasper, Anthony ^a   Bearn, Jenny ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST PATRICK S HOSPITAL   (Ireland)

Author keywords

Dependence; Emergency department; Gamma hydroxybutyrate; GHB; Treatment; Withdrawal

Indexed keywords

1,4 BUTANEDIOL; 4 HYDROXYBUTYRIC ACID; ANTICONVULSIVE AGENT; BACLOFEN; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BROMOCRIPTINE; CARBAMAZEPINE; CHLORAL HYDRATE; CLONIDINE; DIAZEPAM; GABAPENTIN; GAMMA BUTYROLACTONE; LABETOLOL; LORAZEPAM; NEUROLEPTIC AGENT; PENTOBARBITAL; PHENOBARBITAL; PROPOFOL; PROPRANOLOL; SEDATIVE AGENT; THIAMINE; UNCLASSIFIED DRUG; VALPROIC ACID;

ALCOHOL WITHDRAWAL; ALGORITHM; ARTICLE; CLINICAL FEATURE; DEATH; DELIRIUM; DISEASE COURSE; DRUG DEPENDENCE; DRUG EFFICACY; ELECTRONIC MEDICAL RECORD; FATALITY; HUMAN; INGESTION; NONHUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRECURSOR; PRIORITY JOURNAL; PSYCHOSIS; PUBLICATION; SYMPTOM; TREATMENT OUTCOME; WERNICKE ENCEPHALOPATHY; WITHDRAWAL SYNDROME;

EID: 3042549688     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2004.01.012     Document Type: Review

References (25)

1. Addolorato G., Caputo F., Capristo E., Bernardi M., Stefanini G.F., Gasbarrini G. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration. Clin. Neuropharmacol. 22:1999;60-62
2. Addolorato G., Castelli E., Stefanini G.F., Casella G., Caputo F., Marsigli L., Bernardi M., Gasbarrini G. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group Alcohol Alcohol. 31:1996;341-345
3. Bowles T.M., Sommi R.W., Amiri M. Successful management of prolonged gamma-hydroxybutyrate and alcohol withdrawal. Pharmacotherapy. 21:2001;254-257
4. Carai M.A., Colombo G., Brunetti G., Melis S., Serra S., Vacca G., Mastinu S., Pistuddi A.M., Solinas C., Cignarella G., Minardi G., Gessa G.L. Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur. J. Pharmacol. 428:2001;315-321
5. Craig K., Gomez H.F., McManus J.L., Bania T.C. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J. Emerg. Med. 18:2000;65-70
6. Dill C., Shin S. High-dose intravenous benzodiazepine. Acad. Emerg. Med. 7:2000;308-310
7. Dyer J.E., Andrews K.M. Gamma-hydroxybutyrate withdrawal. J. Toxicol. Clin. Toxicol. 35:1997;553-554
8. Dyer J.E., Roth B., Hyma B.A. Gamma-hydroxybutyrate withdrawal syndrome. Ann. Emerg. Med. 37:2001;147-153
9. Friedman J., Westlake R., Furman M. "Grievous bodily harm": gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome. Neurology. 46:1996;469-471
10. Gallimberti L., Spella M.R., Soncini C.A., Gessa G.L. Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol. 20:2000;257-262
11. Galloway G.P., Frederick S.L., Staggers F. Jr. Physical dependence on sodium oxybate. Lancet. 343:1994;57
12. Galloway G.P., Frederick S.L., Staggers F.E. Jr., Gonzales M., Stalcup S.A., Smith D.E. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction. 92:1997;89-96
13. Galloway G.P., Frederick-Osborne S.L., Seymour R., Contini S.E., Smith D.E. Abuse and therapeutic potential of gamma-hydroxybutyric acid. Alcohol. 20:2000;263-269
14. Hechler V., Ratomponirina C., Maitre M. Gamma-hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide. J. Pharmacol. Exp. Ther. 281:1997;753-760
15. Hernandez M., McDaniel C.H., Costanza C.D., Hernandez O.J. GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid. Am. J. Drug Alcohol Abuse. 24:1998;179-183
16. Hutto B., Fairchild A., Bright R. Gamma-hydroxybutyrate withdrawal and chloral hydrate. Am. J. Psychiatry. 157:2000;1706
17. Mahr G., Bishop C.L., Orringer D.J. Prolonged withdrawal from extreme gamma-hydroxybutyrate (GHB) abuse. Psychosomatics. 42:2001;439-440
18. McDaniel C.H., Miotto K.A. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. J. Psychoactive Drugs. 33:2001;143-149
19. Miglani J.S., Kim K.Y., Chahil R. Gamma-hydroxybutyrate withdrawal delirium: a case report. Gen. Hosp. Psychiatry. 22:2000;213-215
20. Miotto K., Darakjian J., Basch J., Murray S., Zogg J., Rawson R. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am. J. Addict. 10:2001;232-241
21. Nicholson K.L., Balster R.L. GHB: a new and novel drug of abuse. Drug Alcohol Depend. 63:2001;1-22
22. Price G. In-patient detoxification after GHB dependence. Br. J. Psychiatry. 177:2000;181
23. Schneir A.B., Ly B.T., Clark R.F. A case of withdrawal from the GHB precursors gamma-butyrolactone and 1, 4-butanediol. J. Emerg. Med. 21:2001;31-33
24. Sivilotti M.L., Burns M.J., Aaron C.K., Greenberg M.J. Pentobarbital for severe gamma-butyrolactone withdrawal. Ann. Emerg. Med. 38:2001;660-665
25. SPSS, 1999. SPSS for Windows: Base System User's Guide. Release 10.0, SPSS Inc., Chicago, IL.